Technology & AI

Anthropic plans IPO while pushing into drug research

The AI company, which is seeking a Nasdaq listing under the ticker ANT, has shared early findings from work with six research partners.

By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .

This story is no longer being updated. It reflects reporting up to .

What happened

Anthropic is planning an initial public offering on Nasdaq under the ticker ANT. The company has shared early findings from its drug programs with six partners, including Bristol Myers Squibb. It has also been running its own drug programs after acquiring a one-person biotech.

Why it matters

Anthropic says it hopes its AI systems will match top human experts across scientific fields.

Coverage

More on this story

More from Technology & AI

All Technology & AI news · Technology & AI story archive